tirzepatide alzheimer Alzheimer's Research: Current Evidence and Future Directions Prevention of Dementia with GLP-1

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads

ncretin-based medicines like Ozempic have shown promising results in studies for reducing alcohol and substance abuse.

PlexusDx offers single-agent tirzepatide therapy and genetic-guided protocols that deliver results without dangerous polypharmacy complications

Generic semaglutide will not be available until at least 2031 in the U.S., when Novo Nordisks patents begin expiring.

But now, GLP-1 weight-loss medications offer a tempting short-cut to thinness.

Semaglutide (Ozempic) stimulates insulin production, helping balance blood glucose levels and reducing appetite